B. Markman
Impact in
Papers in
- Oncology 11
- Cancer Immunotherapy and Biomarkers 7
- Pancreatic and Hepatic Oncology Research 2
- Lung Cancer Research Studies 2
- HER2/EGFR in Cancer Research 2
- CAR-T cell therapy research 2
-
- PI3K/AKT/mTOR signaling in cancer 5
- Co-authors
- José Baselga (3 shared papers)Manuela Gili (1 shared paper)Neal Rosen (1 shared paper)Yasir H. Ibrahim (1 shared paper)Sarat Chandarlapaty (1 shared paper)Olga Rodríguez (1 shared paper)Sharat Singh (1 shared paper)Maurizio Scaltriti (1 shared paper)
- Journals
- Annals of Oncology (8 papers)Journal of Clinical Oncology (4 papers)Cancer Research (2 papers)Molecular Cancer Therapeutics (1 paper)Oncogene (1 paper)
- Partner nations
- AustraliaUnited StatesSpain
In The Last Decade
B. Markman
20 papers receiving 704 citations
Peers
Comparison fields: 5 of 67
- Oncology 261
- Genetics 88
- Molecular Biology 442
- Pulmonary and Respiratory Medicine 133
- Pathology and Forensic Medicine 74
Countries citing papers authored by B. Markman
This map shows the geographic impact of B. Markman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Markman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Markman more than expected).
Fields of papers citing papers by B. Markman
This network shows the impact of papers produced by B. Markman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Markman. The network helps show where B. Markman may publish in the future.
Co-authors
The 25 scholars most cited alongside B. Markman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 448 | |
| 2 | 2012 | 121 | |
| 3 | 2009 | 35 | |
| 4 | 2017 | 29 | |
| 5 | 2008 | 21 | |
| 6 | 2019 | 17 | |
| 7 | 2017 | 11 | |
| 8 | 2008 | 10 | |
| 9 | 2010 | 6 | |
| 10 | 2025 | 3 | |
| 11 | 2017 | 3 | |
| 12 | 2023 | 3 | |
| 13 | 2019 | 2 | |
| 14 | 2018 | 2 | |
| 15 | 2020 | 2 | |
| 16 | 2021 | 2 | |
| 17 | 2020 | 1 | |
| 18 | 2019 | 1 | |
| 19 | 2008 | 1 | |
| 20 | Membrane receptors as targets for therapeutic approaches in colorectal cancer | 2010 | 1 |
About B. Markman
B. Markman is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Surgery, having authored 20 papers that have together received 719 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), Lung Cancer Treatments and Mutations (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Pancreatic and Hepatic Oncology Research (2 papers), Lung Cancer Research Studies (2 papers), HER2/EGFR in Cancer Research (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Oncology (261 citations), Genetics (88 citations), Molecular Biology (442 citations), Pulmonary and Respiratory Medicine (133 citations) and Pathology and Forensic Medicine (74 citations). B. Markman has collaborated with scholars based in Australia, United States and Spain. Frequent co-authors include José Baselga, Manuela Gili, Neal Rosen, Yasir H. Ibrahim, Sarat Chandarlapaty, Olga Rodríguez, Sharat Singh, Maurizio Scaltriti, Josep-Lluís Parra and Sarai Rodríguez. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Cancer Research, Molecular Cancer Therapeutics and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.